Petri, Michelle - Johns Hopkins University

个人简介

Michelle Petri, M.D. is a Professor of Medicine at the Johns Hopkins University School of Medicine. She attended medical school at Harvard University and fulfilled her internal medicine residency at the Massachusetts General Hospital. In addition, she completed two fellowship programs at the University of California, San Francisco in allergy and immunology and rheumatology. Dr. Petri is the Director of the Hopkins Lupus Cohort, a longitudinal study of morbidity and mortality in systemic lupus erythematosus, and Co-Director of the Hopkins Lupus Pregnancy Center. MD, Harvard Medical School (1980)

研究领域

Lupus; Antiphospholipid Syndrome

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Petri, M, Genovese, M, Engle, E, Hochberg, M. Definition, Incidence and Clinical Description of Flare in Systemic Lupus Erythematosus: A Prospective Cohort Study. Arthritis Rheum 34:937-944, 1991. Petri M, Roubenoff R, Nadeau MR, Selhub J, Rosenberg IH. Plasma homocysteine is a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 348:1120-1124, 1996. Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 43:1801-1808, 2000. Ho A, Magder LS, Barr SG, Petri M. Decreases in anti-double stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum 44:2342-2349, 2001. Petri MA, Measse PJ, Merrill JT, Lahita RG, Iannini MJ, Yocum DE, et al. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus: results of a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum 50:2858-2868, 2004. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353:2550-2558, 2005. Petri M, Kiani AN, Christopher-Stine L, Magder L. Coronary calcium in SLE is associated with traditional cardiovascular risk factors, but not with disease activity. J Rheumatol 35:1300-1306, 2008. Petri M, Naqibuddin M, Carson KA, Sampedro M, Wallace DJ, Weisman MH, et al. Cognitive function in systemic lupus erythematosus inception cohort. J Rheumatol 35:1776-1781, 2008. Petri M, Kiani AN, Post W, Christopher-Stine L, Magder LS. Lupus Atherosclerosis Prevention Study (LAPS). Ann Rheum Dis 2010 Dec 10. [Epub ahead of print]. Petri M, Orbai A-M, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of Systemic Lupus International Collaborating Clinics (SLICC) classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677-2686, 2012. Magder LS, Petri M. Incidence of and Risk Factors for Adverse Cardiovascular Events Among Patients With Systemic Lupus Erythematosus. Amer J Epidemiol 176:708-19, 2012. Petri M, Bello KJ, Fang H, Magder LS. Vitamin D in systemic lupus erythematosus: modest association with disease activity and urine protein-to-creatinine ratio. Arthritis Rheum 65:1865-71, 2013.